The origin of monkeypox outbreaks in non-endemic nations – News-Medical.Net

In a recent review posted to the OSF* preprint server, the author explained the causes of the mysterious origin of the recent monkeypox outbreaks in non-endemic nations outside Africa.

Monkeypox cases are on the rise in several non-endemic nations worldwide despite the absence of travel links and connected clusters with Africa. Despite the worldwide prevalence, the causes of the origin of monkeypox beyond the African continent are unclear. If the much more fatal Ebola virus emerges similarly, serious consequences for human health could be expected, and therefore, the origin of the mysterious monkeypox outbreaks must be understood.

In the present review, researchers reported on the causes of the origin of monkeypox outbreaks in several non-endemic nations across the globe.

The recent monkeypox outbreaks cannot be explained based on logical conclusions of data obtained by experimental analysis but by illustrating the reality and making logical deductions only to obtain consequences that must agree with experiences.

The effects of causative pathogens that allow immune pathways to protect organisms from acquiring infections by those pathogens are not dependent on the exclusive nature of a certain pathogen but on the immunological nature in which the pathogenic effects are shared with sterile cause effects.

Immunological mechanisms that decrease pathogen load among animals may not necessarily decrease the disease severity or render the diseases asymptomatic. This is supported by lower severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) loads reported in few severe SARS-CoV-2 infections compared to asymptomatic and mild SARS-CoV-2 infections. The findings indicate that the severity of a disease depends on the hyper-inflammatory state instead of the direct effects of pathogen toxicity.

Therefore, outbreaks of infections that have been considered asymptomatic do not necessarily require pathogenic transmission but instead the disappearance of several conditions that allow immunological mechanisms to consider them asymptomatic without eliminating the disease causes.

Different diseases with different causes but with pathological effects of identical immunology may present with different manifestations in the absence of the pathogen (monkeypox virus). Different causes with effects of the same immunological nature manifest concomitantly in monkeypox cases and are already present in individuals in non-endemic nations. Therefore, monkeypox outbreaks have appeared in regions beyond the African continent, despite the absence of travel links and connected clusters with Africa.

Researchers have made relentless efforts to characterize the genetic basis for the widespread global prevalence of the monkeypox in the central parts of Africa compared to the western regions of Africa. It has been assumed that the pathogens responsible for central African outbreaks have higher transmissibility and virulence than those responsible for the outbreaks in West Africa.

However, a common observation among all monkeypox case clusters is exposure to factors facilitating the disappearance of conditions that allow immunological mechanisms to render monkeypox asymptomatic without eliminating etiological factors of the same immunological nature. Therefore, the origin of monkeypox in non-endemic zones is not dependent on the transmissibility or virulence of the monkeypox virus but on the disappearance (and reappearance) of conditions in response to which the manifestations of monkeypox appear.

Furthermore, the manifestations of an infection linked to a particular pathogenic organism are as diverse as the disappearance of conditions that allow the immune system and different driving factors of the same immunology to give rise to concomitant asymptomatic infections. The severity of the manifestations is comparable to those of infections sharing the same immunology, independent of the transmissibility and virulence of the pathogenic organism.

The manifestations linked to pathogens would cause catastrophic effects in individuals even in the absence of the causative pathogen if factors cause fading away of conditions that allow infections with the same immunology to be considered asymptomatic. Such infections could spread extensively within a short period.

Based on the findings, further research must explore the immunological nature of the more fatal Ebola virus infections and identify different diseases that share similar immunology as that of Ebola infection, respectively.

Such an approach would be more beneficial in preventing the probable catastrophic effects of Ebola infections instead of investigating the genetic basis of Ebola virus infections or the transmissibility and virulence of the Ebola virus. In addition, factors that allow immunological mechanisms to consider Ebola virus infections to be asymptomatic must be determined.

OSF publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information.

Read this article:
The origin of monkeypox outbreaks in non-endemic nations - News-Medical.Net

Battle of the Vaccines: Inhaled is Better than Nasal Sprays – Laboratory Equipment

Michael D'Agostino demonstrates the aerosol delivery method, which in this study was done on animal models. Credit: McMaster University

McMaster University scientists who compared respiratory vaccine-delivery systems have confirmed that inhaled aerosol vaccines provide far better protection and stronger immunity than nasal sprays.

While nasal sprays reach primarily the nose and throat, inhaled aerosols bypass the nasal passage and deliver vaccine droplets deep in the airway, where they can induce a broad protective immune response, the researchers report.

For the study, published online in the journalFrontiers in Immunology, the researchers used a tuberculosis vaccine to compare delivery methods by measuring the distribution of droplets, immune responses and potency in animals.

When the vaccine was delivered directly into the lungs it stimulated stronger immune responses, providing much better protection from TB.

Infections in the upper respiratory tract tend to be non-severe. In the context of infections caused by viruses like influenza or SARS-CoV-2, it tends to be when the virus gets deep into the lung that it makes you really sick, explains Matthew Miller, a co-author of the study who holds the Canada Research Chair in Viral Pandemics at McMaster University.

The immune response you generate when you deliver the vaccine deep into the lung is much stronger than when you only deposit that material in the nose and throat because of the anatomy and nature of the tissue and the immune cells that are available to respond are very different, says Miller, who is alsoan investigator with Canadas Global Nexus for Pandemics & Biological Threats, which is based at McMaster.

This study for the first time provides strong preclinical evidence to support the development of inhaled aerosol delivery over nasal spray for human vaccination against respiratory infections including TB, COVID-19 and influenza, says Zhou Xing, co-investigator of the study and a professor at the McMaster Immunology Research Centre and Department of Medicine.

More than 6.3 million have people died during the COVID-19 pandemic, and respiratory infections remain a significant cause of illness and death throughout the world, driving an urgent and renewed worldwide effort to develop vaccines that can be delivered directly to the mucous lining of the respiratory tract.

Scientists at McMaster, who have developed a unique inhaled form of COVID vaccine,believe this deep-delivery method offers the best defence against the current and future pandemics.

APhase 1 clinical trialis currently under way to evaluate the inhaled aerosol vaccine in healthy adults who had previously received two or three doses ofan injected COVID mRNA vaccine.

Nasal mist flu vaccines have been shown to be highly effective in children, but much less effective in adults, leaving injectable flu vaccines as the most popular choice for seasonal flu vaccinations.

Previous research by the McMaster team has shownthat in addition to being needle-free and painless, an inhaled vaccine is so efficient at targeting the lungs and upper airways that it can achieve maximum protection with a much smaller dose than injected vaccines.

Republished courtesy of McMaster University.

Read more from the original source:
Battle of the Vaccines: Inhaled is Better than Nasal Sprays - Laboratory Equipment

22pc of people tested for Covid-19 are positive as a ‘return to normal’ sees cases rise – Independent.ie

Twenty-two percent of people tested for Covid-19 are positive as cases are rising, an immunology expert has said.

rofessor of Experimental Immunology at Trinity College Dublin Kingston Mills, said the fact that people are back to normal has contributed to a rise in cases.

"The number of cases has risen here, but its not just in Ireland.In the UK, Portugal and Germany, there has been a risein the past couple of weeks, he said on RT Radio 1s This Week.

"This is really on the back of the variants BA.4, BA.5, theseare sub-variants of Omicron, which are distinct from the original Omicron, they have mutated further. They are moretransmissible.

Mr Mills also pointed to the fact that people are now back to normal, and there's no social distancing, no mask-wearing.

There is a lot of contact,a lot of hospitality, so all of that is contributing to the rising case numbers.

He pointed out that the numbers in hospital are rising, so that does suggest that the case numbers are rising.

As of 8am, there were 397 people in hospital with Covid-19, this is an increase of 37 from yesterdays statistics.

The positivity rate of those that are tested has gone up from16 to 22pc, ProfMills said.

"So 22pc of all people that are tested are turning out to be positive, andthats an indication that we are getting an increase in the number of cases, as well as the number ofhospitalisations.

Omicron and its sub-variants largely infect theupper respiratory tract and they dont go as much into the lung, unless somebody has an underlying lung condition.

Prof Mills said that for a normal, healthy person this is not a very serious disease, but for people who are older, or people with underlying medical conditions or on some immunotherapy that might make their immune system suppressed, it is still a concern.

And these are the ones that are vulnerable now. It's important that if they havent been vaccinated with a fourth dose, or have recently had Covid, they should get a booster vaccine."

Prof Mills saidhe knew of a lot of older people, and people with underlying health conditions who havent yet had Covid who are still worried about getting it, because they feel that they may end up in hospital if they do get it and that is a big concern.

"And that is the big worry in this with increasing case numbers, it isinevitable that some will end up in hospital.

For the normal healthy person, its not a big deal getting this infection, in fact getting the infection now, especially if youve had the vaccine, three doses of the vaccine, will add to your immunity and probably prevent you from getting re-infected at this stage.

But the trouble is, even getting infected with the original Omicron is not now having as much protection against reinfection with B.A4 and B.A5 and thats the worry about this virus, it keeps changing and if it changes again, that will make it even more difficult for the vaccines to work.But the good news is the vaccines do prevent severe disease."

Prof Mills said those who have had their vaccine doses are in a better place than those who have not been vaccinated.

There is a lot of concern for those who are not vaccinated in the older age group or with underlying medical conditions, he said.

The rest is here:
22pc of people tested for Covid-19 are positive as a 'return to normal' sees cases rise - Independent.ie

Online Biochemistry Course | MCAT or Med School Prep | Arizona Online

University of Arizona Privacy Statement

View the University of Arizona's Privacy Statement

View the University of Arizonas electronic privacy policy

The University of Arizona Online website collects anonymous visitor data using Google Analytics. We utilize first- and third-party cookies to measure website and campaign effectiveness, but no personal information is collected automatically.

Remarketing with Google AnalyticsGoogle Display Network Impression ReportingDoubleClick Platform integrationsGoogle Analytics Demographics and Interest Reporting

More information about Googles user data security policy for Google AnalyticsYou can opt out of Google Analytics tracking by installing this browser extension

By entering and submitting information in any Request for Information form on the University of Arizona Online website, you consent to being contacted via phone, email, text message and/or pre-recorded message by the University of Arizona Online and its affiliates.

See the original post here:
Online Biochemistry Course | MCAT or Med School Prep | Arizona Online

University of Utah Health Biochemist Matt Miller Named Pew Scholar – University of Utah Health Care

Jun 14, 2022 8:00 AM

Matthew Miller, Ph.D., an assistant professor of biochemistry at University of Utah Health, was named as a 2022 Pew Scholar for his exploration of the cellular machines that help accurately divide and separate chromosomes during cell division. This work is critical as even the smallest errors in this process can have harmful consequences, including birth defects, miscarriages, and cancer.

Miller is one of 22 scientists nationwide to receive the honor from the Pew Charitable Trusts. The Pew Scholars Program in the Biomedical Sciences provides funding to early-career investigators of outstanding promise in science that is relevant to the advancement of human health.

Millers research focuses on a key phase of cell division, or mitosis, when protein-based machines called kinetochores help chromosomes correctly maneuver between parent and newly forming daughter cells. This process ensures that each cell receives a complete set of accurately replicated chromosomes.

Better understanding of how kinetochores work could lead to the development of genetic interventions or other treatments to reduce the risk of these disorders, Miller says.

Matt Miller is studying a truly fascinating and red-hot area of research, says Wes Sundquist, Ph.D., a former Pew Scholar and chair of the Department of Biochemistry at the University of Utah Health. To address this problem, Matt uses an amazingmulti-disciplinary combination of biochemistry, biophysics, genetics, and cell biology for which he is almost uniquely qualified owing to his wonderful breadth, insight, and creativity.

Understanding the process of chromosome separation during mitosis is a difficult challenge, according to Miller. Thats because of its dynamic nature and the inability to precisely replicate the physical forces that regulate these activities in cells.

To overcome this difficulty, Miller and his colleagues purify the protein machines involved and have developed techniques which allow them to reestablish their complex activities outside of a cell. This allows the researchers to experimentally control things such as applied physical force and ultimately understand how these factors carry out this process so reliably.

Kinetochores are incredible protein machines, Miller says. They move chromosomes within an ever-changing environment and are signaling hubs that help regulate the cell cycle. Biologists have been fascinated with this process for more than 100 years, yet we still dont know how kinetochores achieve their remarkable feats.

In fact, according to Miller, scientists still dont have a complete parts list for the inner workings of kinetochores. Its like knowing that an internal combustion engine makes a car run but not understanding that under the hood it is a collection of pistons, spark plugs, and other vital moving parts, he says.

Despite this, Miller and his colleagues are unraveling several key aspects of kinetochores and their role in cell division.

During cell division, the cells genetic information, or DNA, is packaged into structures known as chromosomes, which need to be copied and then partitioned equally between resulting daughter cells. To facilitate this process, kinetochores assemble on chromosomes and attach themselves to the mitotic spindle, a molecular machine that forms thin, thread-like strands called microtubules. Once they do this, the duplicated chromosomes can move to opposite ends of the parent cell in preparation for cell division.

If kinetochores dont do their job correctly, then the chromosomes wont divide evenly, and one cell could end up with too many or too few of them. As a result, harmful imbalances and mutations can occur, Miller says.

Fortunately, these types of errors are rare. So what keeps the chromosomes attached to the right microtubules? It all boils down to tension, Miller says.

To accurately segregate replicated chromosomes to daughter cells, the chromosome must attach to microtubules from opposite sides of the cell. This pulling from opposite sides generates tension, telling the cell it has the correct attachment configuration and can proceed with cell division. Miller and colleagues recently discovered that kinetochores have an intrinsic mechanism that senses this tension. It acts, Miller says, like a childs finger trap, a simple puzzle that traps fingers in both ends of a small cylinder woven from bamboo. The harder a person tries to pull their fingers out, the tighter the device gets.

In much the same way, the tension created by the force of opposing microtubule pulling keeps the chromosomes aligned properly. When the kinetochores sense the right amount of tension, they give the go-ahead signal and then move each of their chromosomes to opposite sides of the parent cell, enabling accurate cell division.

Using an array of cutting-edge tools in biochemistry, biophysics, and gene editing, Miller hopes to determine which parts of the protein machines are responsible forchromosomal attachment and segregation.

We will then reconstitute the activities of these protein machines in a test tube to discover the mechanisms these protein machines use to carry out this process, Miller says. This work could lead to novel strategies for reducing the chromosomal segregation defects that give rise to many human diseases, including cancer and developmental disorders such as Down syndrome.

The 2022 class of Pew scholarsall early-career, junior facultywill receive four years of funding to explore some of the most pressing questions in health and medicine. They were chosen from 197 applicants nominated by leading academic institutions and researchers across the United States.

####

Research News Biochemistry Pew Scholar

Read the rest here:
University of Utah Health Biochemist Matt Miller Named Pew Scholar - University of Utah Health Care

UMass Amherst’s Up-and-coming Biochemists Are Already Recruiting the Next GenerationWith Strawberries – UMass News and Media Relations

Many students love their undergraduate major. But for students in the UMass Amherst Biochemistry Club, spending extra hours in the lab isnt enough. Thanks to a grant from the American Society for Biochemistry and Molecular Biology (ASBMB), club members spent this past spring semester working with high school students in the Holyoke Public Schools to help plant the seeds for the next generation of up-and-coming biochemists. Their secret? Strawberries.

The Holyoke Public School system is currently under state receivership after being designated in 2015 as chronically underperforming. The district has been working to increase graduation rates, and as part of this goal, Holyoke High School has been redesigned to let each student choose a pathway that will prepare them for success in college, in a career or in community leadership. One of these pathways is the Medical and Life Sciences Pathway, designed to develop problem solving, critical thinking and communication skills for students interested in the biological sciences and healthcare. The UMass Biochem Club worked specifically with this cohort, performing experiments with them and conducting Q-and-A panels.

One of these experiments involved extracting DNA from strawberries. Michael Cotto, chair of the science department at Holyoke High School, said that having the opportunity for a hands-on experiment was a great way to welcome students back from their spring vacation. Students were engaged and excited by the science!

Anna Gorfinkel 22 and Ashley Sheehan 22, co-presidents of the Biochem Club, said that Western Massachusetts is a hub of educational opportunities and STEM careers. As students at the University of Massachusetts Amherst, the commonwealths flagship public university, we have a great opportunity to use our proximity to Holyoke to serve as role models for students interested in continuing their education and pursuing careers in the life sciences.

The Biochem Club is the ASBMB Student Chapter for UMass Amherst, and their mission is to help young people foster curiosity and interest in STEM. They have done extensive outreach to local communities since their inception in 2012, including programs at the Amherst-Pelham Regional High School, Girls Inc. of the Valley, and the Holyoke High School.

See the original post:
UMass Amherst's Up-and-coming Biochemists Are Already Recruiting the Next GenerationWith Strawberries - UMass News and Media Relations

New cryo-electron microscopy centers help UW researchers uncover mysteries of life – University of Wisconsin-Madison

At the Steenbock Symposium on June 7 and 8, 2022, the University of WisconsinMadison Department of Biochemistry opened its doors in celebration of two new research centers that bring to campus advanced biomolecular imaging technology called cryo-electron microscopy.

The technology allows scientists to capture detailed information about the smallest components of living cells to understand everything from more effective drug development to how viruses infect cells. It relies on ultra-cold temperatures during biomolecular specimen preservation and imaging and requires the right combination of expertise and highly specialized equipment.

The UWMadison Cryo-Electron Microscopy Research Center and the NIH-sponsored Midwest Center for Cryo-Electron Tomography represent a continuation of UWMadisons long history of contributions to structural biology. The event featured tours of the centers and scientific talks and posters about cryo-EM.

Both centers provide instrumentation, training, technical assistance and support to UWMadison researchers, as well as access to cryo-EM. The centers are also open to other universities and to private industry.

1 Thomas Anderson, a cellular and molecular biology graduate student working in the lab of biochemistry professor Robert Kirchdoerfer, and Anil Kumar, a research specialist in the cryo-EM centers, explain the inner workings of the Titan Krios cryo-electron microscope to their tour group at the Cryo-Electron Microscopy Research Center. Photo by Michael P. King/UW-Madison CALS

2 Industry and campus partnerships are critical to the centers' construction and operation. Zoltan Metlagel, a senior applications engineer at ThermoFisher Scientific, shared his knowledge about tomographic imaging alongside Parrell during one of five interactive workshops held during the open house. Photo by Michael P. King/UW-Madison CALS

3 Joseph Kim, a graduate student in the chemistry department, leads scientists through one of five interactive workshops held during the open house. Dedicated on-site training by center users and staff is available to scientists across campus and beyond. Photo by Michael P. King/UW-Madison CALS

4 Postdoctoral researcher Daniel Parrell explains how to use cryo-electron tomography data to produce an image known as a 3D tomogram. The montage shows biological structures in a thin layer of human cells and was collected using remote access capabilities and a focused ion beam. Remote training and operation of equipment are both features of the new centers. Photo by Michael P. King/UW-Madison CALS

5 Biochemistry professor and Morgridge Institute for Research investigator Elizabeth Wright directs the UWMadison Cryo-Electron Microscopy Research Center, led by a coalition of campus partners, and the NIH-sponsored Midwest Center for Cryo-Electron Tomography. Photo by Robin Davies

6 Open house attendees learned what can be achieved with cryo-EM during scientific talks and poster sessions held in the Discovery Building. Approximately 200 people attended the open house in-person, while another 200 viewed talks and workshops online. Photo by Robin Davies

Read more from the original source:
New cryo-electron microscopy centers help UW researchers uncover mysteries of life - University of Wisconsin-Madison

Caltech Professor of Chemistry and Biochemistry Decodes a Key Part of the Cell, Atom by Atom Pasadena Now – Pasadena Now

Credit: Valerie Altounian

Whatever you are doing, whether it is driving a car, going for a jog, or even at your laziest, eating chips and watching TV on the couch, there is an entire suite of molecular machinery inside each of your cells hard at work. That machinery, far too small to see with the naked eye or even with many microscopes, creates energy for the cell, manufactures its proteins, makes copies of its DNA, and much more.

Among those pieces of machinery, and one of the most complex, is something known as the nuclear pore complex (NPC). The NPC, which is made of more than 1,000 individual proteins, is an incredibly discriminating gatekeeper for the cells nucleus, the membrane-bound region inside a cell that holds that cells genetic material. Anything going in or out of the nucleus has to pass through the NPC on its way.

The NPCs role as a gatekeeper of the nucleus means it is vital for the operations of the cell. Within the nucleus, DNA, the cells permanent genetic code, is copied into RNA. That RNA is then carried out of the nucleus so it can be used to manufacture the proteins the cell needs. The NPC ensures the nucleus gets the materials it needs for synthesizing RNA, while also protecting the DNA from the harsh environment outside the nucleusandenabling the RNA to leave the nucleus after it has been made.

Its a little like an airplane hangar where you can repair 747s, and the door opens to let the 747 come in, but theres a person standing there who can keep a single marble from getting out while the doors are open, says CaltechsAndr Hoelz, professor of chemistry and biochemistry and a Faculty Scholar of the Howard Hughes Medical Institute. For more than two decades, Hoelz has been studying and deciphering the structure of the NPC in relation to its function. Over the years, he has steadily chipped away at its secrets, unraveling thempiecebypiecebypiecebypiece.

The implications of this research are potentially huge. Not only is the NPC central to the operations of the cell, it is also involved in many diseases. Mutations in the NPC are responsible for some incurable cancers, for neurodegenerative and autoimmune diseases such as amyotrophic lateral sclerosis (ALS) and acute necrotizing encephalopathy, and for heart conditions including atrial fibrillation and early sudden cardiac death. Additionally, many viruses, including the one responsible for COVID-19, target and shutdown the NPC during the course of their lifecycles.

Now, in a pair of papers published in the journalScience,Hoelz and his research team describe two important breakthroughs: the determination of the structure of the outer face of the NPC and the elucidation of the mechanism by which special proteins act like a molecular glue to hold the NPC together.

In their paper titled Architecture of the cytoplasmic face of the nuclear pore, Hoelz and his research team describe how they mapped the structure of the side of the NPC that faces outward from the nucleus and into the cells cytoplasm. To do this, they had to solve the equivalent of a very tiny 3-D jigsaw puzzle, using imaging techniques such as electron microscopy and X-ray crystallography on each puzzle piece.

Stefan Petrovic, a graduate student in biochemistry and molecular biophysics and one of the co-first authors of the papers, says the process began withEscherichia colibacteria (a strain of bacteria commonly used in labs) that were genetically engineered to produce the proteins that make up the human NPC.

If you walk into the lab, you can see this giant wall of flasks in which cultures are growing, Petrovic says. We express each individual protein inE. colicells, break those cells open, and chemically purify each protein component.

Once that purificationwhich can require as much as 1,500 liters of bacterial culture to get enough material for a single experimentwas complete, the research team began to painstakingly test how the pieces of the NPC fit together.

George Mobbs, a senior postdoctoral scholar research associate in chemistry and another co- first author of the paper, says the assembly happened in a stepwise fashion; rather than pouring all the proteins together into a test tube at the same time, the researchers tested pairs of proteins to see which ones would fit together, like two puzzle pieces. If a pair was found that fit together, the researchers would then test the two now-combined proteins against a third protein until they found one that fit with that pair, and then the resulting three-piece structure was tested against other proteins, and so on. Working their way through the proteins in this way eventually produced the final result of their paper: a 16-protein wedge that is repeated eight times, like slices of a pizza, to form the face of the NPC.

We reported the first complete structure of the entire cytoplasmic face of the human NPC, along with rigorous validation, instead of reporting a series of incremental advances of fragments or portions based on partial, incomplete, or low-resolution observation, says Si Nie, postdoctoral scholar research associate in chemistry and also a co-first author of the paper. We decided to patiently wait until we had acquired all necessary data, reporting a humungous amount of new information.

Their work complemented research conducted by Martin Beck of the Max Planck Institute of Biophysics in Frankfurt, Germany, whose team used cryo-electron tomography to generate a map that provided the contours of a puzzle into which the researchers had to place the pieces. To accelerate the completion of the puzzle of the human NPC structure, Hoelz and Beck exchanged data more than two years ago and then independently built structures of the entire NPC. The substantially improved Beck map showed much more clearly where each piece of the NPCfor which we determined the atomic structureshad to be placed, akin to a wooden frame that defines the edge of a puzzle, Hoelz says.

The experimentally determined structures of the NPC pieces from the Hoelz group served to validate the modeling by the Beck group. We placed the structures into the map independently, using different approaches, but the final results completely agreed. It was very satisfying to see that, Petrovic says.

We built a framework on which a lot of experiments can now be done, says Christopher Bley, a senior postdoctoral scholar research associate in chemistry and also co-first author. We have this composite structure now, and it enables and informs future experiments on NPC function, or even diseases. There are a lot of mutations in the NPC that are associated with terrible diseases, and knowing where they are in the structure and how they come together can help design the next set of experiments to try and answer the questions of what these mutations are doing.

This elegant arrangement of spaghetti noodles

In the other paper, titled Architecture of the linker-scaffold in the nuclear pore, the research team describes how it determined the entire structure of what is known as the NPCs linker-scaffoldthe collection of proteins that help hold the NPC together while also providing it with the flexibility it needs to open and close and to adjust itself to fit the molecules that pass through.

Hoelz likens the NPC to something built out of Lego bricks that fit together without locking together and are instead lashed together by rubber bands that keep them mostly in place while still allowing them to move around a bit.

I call these unstructured glue pieces the dark matter of the pore,' Hoelz says. This elegant arrangement of spaghetti noodles holds everything together.

The process for characterizing the structure of the linker-scaffold was much the same as the process used to characterize the other parts of the NPC. The team manufactured and purified large amounts of the many types linker and scaffold proteins, used a variety of biochemical experiments and imaging techniques to examine individual interactions, and tested them piece by piece to see how they fit together in the intact NPC.

To check their work, they introduced mutations into the genes that code for each of those linker proteins in a living cell. Since they knew how those mutations would change the chemical properties and shape of a specific linker protein, making it defective, they could predict what would happen to the structure of the cells NPCs when those defective proteins were introduced. If the cells NPCs were functionally and structurally defective in the way they expected, they knew they had the correct arrangement of the linker proteins.

A cell is much more complicated than the simple system we create in a test tube, so it is necessary to verify that results obtained from in vitro experiments hold up in vivo, Petrovic says.

The assembly of the NPCs outer face also helped solve a longtime mystery about the nuclear envelope, the double membrane system that surrounds the nucleus. Like the membrane of the cell within which the nucleus resides, the nuclear membrane is not perfectly smooth. Rather, it is studded with molecules called integral membrane proteins (IMPs) that serve in a variety of roles, including acting as receptors and helping to catalyze biochemical reactions.

Although IMPs can be found on both the inner and outer sides of the nuclear envelope, it had been unclear how they actually traveled from one side to the other. Indeed, because IMPs are stuck inside of the membrane, they cannot just glide through the central transport channel of the NPC as do free-floating molecules.

Once Hoelzs team understood the structure of the NPCs linker-scaffold, they realized that it allows for the formation of little gutters around its outside edge that allow the IMPs to slip past the NPC from one side of the nuclear envelope to the other while always staying embedded in the membrane itself.

It explains a lot of things that have been enigmatic in the field. I am very happy to see that the central transport channel indeed has the ability to dilate and form lateral gates for these IMPs, as we had originally proposed more than a decade ago, Hoelz says.

Taken together, the findings of the two papers represent a leap forward in scientists understanding of how the human NPC is built and how it works. The teams discoveries open the door for much more research. Having determined its structure, we can now focus on working out the molecular bases for the NPCs functions, such as how mRNA gets exported and the underlying causes for the many NPC-associated diseases with the goal of developing novel therapies, Hoelz says.

The papers describing the work appear in the June 10 issue of the journalScience.

Additional co-authors of the paper, Architecture of the cytoplasmic face of the nuclear pore, are Anna T. Gres; now of Worldwide Clinical Trials; Xiaoyu Liu, now of UCLA; Sho Harvey, a former grad student in Hoelzs lab; Ferdinand M. Huber, now of Odyssey Therapeutics; Daniel H. Lin, now of the Whitehead Institute for Biomedical Research; Bonnie Brown, a former research technician in Hoelzs lab; Aaron W. Tang, a former research technician in Hoelzs lab; Emily J. Rundlet, now of St. Jude Childrens Research Hospital and Weill Cornell Medicine; Ana R. Correia, now of Amgen; Taylor A. Stevens, graduate student in biochemistry and molecular biophysics; Claudia A. Jette, graduate student in biochemistry and molecular biophysics; Alina Patke, research assistant professor of biology; Somnath Mukherjee and Anthony A. Kossiakoff of the University of Chicago; Shane Chen, Saroj G. Regmi, and Mary Dasso of the National Institute of Child Health and Human Development; and Alexander F. Palazzo of the University of Toronto.

Additional co-authors of the paper, Architecture of the linker-scaffold in the nuclear pore, are Dipanjan Samanta, postdoctoral scholar fellowship trainee in chemical engineering; Thibaud Perriches, now of Care Partners; Christopher J. Bley; Karsten Thierbach; now of Odyssey Therapeutics; Bonnie Brown, Si Nie, George W. Mobbs, Taylor A. Stevens, Xiaoyu Liu, now of UCLA; Giovani Pinton Tomaleri, graduate student in biochemistry and molecular biophysics; and Lucas Schaus, graduate student in biochemistry and molecular biophysics.

Funding for the research was provided by the National Institutes of Health, the Howard Hughes Medical Institute, and the Heritage Medical Research Institute.

Get all the latest Pasadena news, more than 10 fresh stories daily, 7 days a week at 7 a.m.

See the original post here:
Caltech Professor of Chemistry and Biochemistry Decodes a Key Part of the Cell, Atom by Atom Pasadena Now - Pasadena Now

Cleanup duty | University of Minnesota – UMN News

When COVID-19 began surging around the world in early 2020 and physicians were confronting a deadly disease they knew little about, scientists at the University of Minnesotas Institute on the Biology of Aging and Metabolism (iBAM) swung into action to help.

Early in the pandemic it became very clear that certain people were at greatest riskthe elderly, people with diabetes, and people with obesity, says Laura Niedernhofer, professor of biochemistry in the Medical School and director of iBAM. And one common thread between those groups? They all have increased levels of senescent cells.

Senescent cells are aging cells that have stopped dividing but havent died. According to Niedernhofer, the burden of senescent cells in our body doubles with every decade of life.

Senescent cells drive inflammation, and that inflammation then puts you at greater risk for disease and aging, explains iBAM associate director Paul Robbins, also a professor of biochemistry in the Medical School. If you have a perfectly healthy, robust immune system, your body clears these cells for you. But as we age, our immune response wanes and stops clearing these cells effectively.

Niedernhofer, Robbins, and their iBAM colleagues didnt wait to be asked if their research into senescent cells could be applied to fight COVID-19 infections, too. This was really an instant reaction, recalls Niedernhofer. Were here to think about the biology of aging, but more importantly, were here to help older Minnesotans. We felt it was our obligation to do everything we could to help rescue our most vulnerable populations from the lethality of COVID-19.

What if there were a drug that could help clear senescent cells and slow the onset of not just the aging process, but of the many diseases associated with aging, such as heart disease, cancer, type 2 diabetes, and Alzheimers disease?

That question led Niedernhofer and Robbins, working with colleagues at the Mayo Clinic, to become the first scientists to describe a new class of drugs called senolytics in 2015. More recently, theyve shown that fisetin, a natural antioxidant found in various fruits and vegetables (apples, strawberries, onions, and cucumbers, for example), successfully clears senescent cells in mice.

We do have preliminary data [indicating] that fisetin clears senescent cells in humans, says Niedernhofer, and there are now many clinical trials underway to study it further.

When COVID-19 struck, iBAM scientists quickly geared up to see whether the senolytics they were developing to promote healthier aging could also be used to treat the viral infection caused by SARS-CoV-2.

In a study led by iBAM investigator Christina Camell, researchers exposed aged mice to a coronavirus closely related to SARS-CoV-2. In the control group, all of the infected mice died; mice treated with a senolytic, however, had a 5060% survival rate.

The excitement around senolytics as a COVID-19 treatment has been growing, says Camell, since the groups results were published last summer in the prestigious journal Science. Clinical studies are under way in Minnesota to evaluate the success of treating COVID-19 patients with senolytics.

Investment to outcomes

In 2015, the Minnesota Legislatures higher education funding bill included an unprecedented $30 million investment that allowed the U of Ms Medical School to establish four new Medical Discovery Teams (MDTs). The MDTs were designed to propel already strong programs into world-class research cohorts dedicated to addressing some of the states most pressing health care priorities: addiction, rural and Native American health, optical imaging and brain science, and the biology of aging.

That investment brought top researchers like Niedernhofer and Robbins to the U to continue building on their leading-edge research.

The University of Minnesota has been an incredibly rich backdrop for our work studying the biology of aging, says Niedernhofer, providing so many opportunities for collaborations with colleagues across campus to find new applications for senolytics in treating diseases in the elderly.

And with the states (and the worlds) aging population growing, theres no better time for progress.

Were living in a time on this planet where the elderly population is doubling, says Niedernhofer, and each of those elderly people has an average of two chronic diseases. By targeting the biology of aging itself, instead of targeting specific diseases, with this new class of drugs called senolytics, we may be able to help people live healthier for a longer time.

View post:
Cleanup duty | University of Minnesota - UMN News

Academic All-Ohio Athletic Conference includes 11 from Alliance area – The-review

Staff report| The Alliance Review

Mount Union had 80 spring sports athletes recognized as Academic All-Ohio Conference.

To be selected an athlete must have a 3.50 cumulative grade point average and maintain varsity status.

These are the area Mount Union students who were selected:

Colton Wade, Marlington, men's golf, senior, Biochemistry, 3.97

Krissy Tarter, Marlington, senior, women's track & field, Biochemistry, 3.94

Grace Heath, West Branch, junior, softball, Accounting and Finance, 3.93

Lily Bogunovich, Marlington, senior, women's track & field, History, 3.91

Jeff Joseph, West Branch, junior, men's track & field, Multi-Platform Software Development, 3.88

Brittany Bolevich, Southeast, junior, women's track & field, Middle Childhood Education, 3.75

Lauren Amodio, Southeast, sophomore, women's golf, Exercise Science, 3.69

Gianini Venuto, Southeast, sophomore, women's track & field, Sport Business, 3.62

Other students from area schools who were selected:

Brendan Stinson, Capital, Marlington, baseball, Business Management

Spencer Hall, Marietta, Louisville, men's tennis, Strategic Communications

Morgan Mullaly, Muskingum, Alliance, women's golf, Early Childhood Education, Special Education

Read the original post:
Academic All-Ohio Athletic Conference includes 11 from Alliance area - The-review